# Small intestinal NK/T-cell lymphoma with malignant peritoneal effusion as the first symptom: a case report and literature review

**Authors:** Bing Zhou, Qihan Zhao, Xiaohua Li, Haoru Liu, Hua Hao

PMC · DOI: 10.3389/fmed.2025.1610820 · Frontiers in Medicine · 2025-07-22

## TL;DR

A rare case of small intestinal NK/T-cell lymphoma presented with malignant peritoneal effusion, highlighting the disease's aggressive nature and diagnostic challenges.

## Contribution

This case report adds to the limited literature on small intestinal NK/T-cell lymphoma presenting with peritoneal effusion as the first symptom.

## Key findings

- Malignant peritoneal effusion was the initial symptom in a case of small intestinal NK/T-cell lymphoma.
- The patient had a poor prognosis despite aggressive treatment, emphasizing the disease's aggressiveness.
- Early detection and clinician awareness are critical for managing this rare lymphoma.

## Abstract

Small intestinal NK/T-cell lymphoma (NK/T-L) is a rare condition, and cases presenting with malignant peritoneal effusion as the initial symptoms are not well-documented. We report a unique case that contributes to the understanding of this rare disease.

A 47-year-old man was admitted to the hospital with a chief complaint of abdominal distension and weight loss persisting for over 2 months. Imaging studies revealed ascites and localized thickening of the small intestine. Paracentesis cytology revealed a significant presence of small-to-medium-sized lymphoid cells. Immunohistochemistry confirmed a diagnosis of T-cell lymphoma. Histological examination confirmed primary NK/T-L of the small intestine after PET-CT excluded metastases from other sites. Despite aggressive chemotherapy, the patient’s condition deteriorated, resulting in his death 4 months later.

This case highlights the importance of considering small intestinal NK/T-L in patients with abdominal symptoms and malignant peritoneal effusion. The aggressive nature and poor prognosis of this disease pose challenges in diagnosis and treatment. Increased awareness among clinicians and pathologists is crucial for early detection and improved patient outcomes.

## Linked entities

- **Diseases:** NK/T-cell lymphoma (MONDO:0019472)

## Full-text entities

- **Genes:** CD5 (CD5 molecule) [NCBI Gene 921] {aka LEU1, T1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, SPN (sialophorin) [NCBI Gene 6693] {aka CD43, GALGP, GPL115, LEU-22, LSN}, TIA1 (TIA1 cytotoxic granule associated RNA binding protein) [NCBI Gene 7072] {aka ALS26, TIA-1, WDM}, AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}, CD3E (CD3 epsilon subunit of T-cell receptor complex) [NCBI Gene 916] {aka CD3epsilon, IMD18, T3E, TCRE}, DDX3X (DEAD-box helicase 3 X-linked) [NCBI Gene 1654] {aka CAP-Rf, DBX, DDX14, DDX3, HLP2, MRX102}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CEACAM3 (CEA cell adhesion molecule 3) [NCBI Gene 1084] {aka CD66D, CEA, CGM1, CGM1a, W264, W282}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, WT1 (WT1 transcription factor) [NCBI Gene 7490] {aka AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, ADA (adenosine deaminase) [NCBI Gene 100] {aka ADA1}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, STAT5B (signal transducer and activator of transcription 5B) [NCBI Gene 6777] {aka GHISID2, STAT5}, CD2 (CD2 molecule) [NCBI Gene 914] {aka LFA-2, SRBC, T11}, MUC16 (mucin 16, cell surface associated) [NCBI Gene 94025] {aka CA125}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}
- **Diseases:** malignant peritoneal effusion (MESH:D010534), hypoproteinemia (MESH:D007019), Ascites (MESH:D001201), adhesions (MESH:D000267), metastases (MESH:D009362), non-Hodgkin lymphoma (MESH:D008228), tuberculous peritonitis (MESH:D014395), effusion (MESH:D000080324), necrosis (MESH:D009336), anemia (MESH:D000740), liver cirrhosis (MESH:D008103), EATL (MESH:D058527), hepatitis (MESH:D056486), NK (MESH:D054066), MEITL (MESH:D016399), T-lymphoproliferative disorders (MESH:D008232), HL (MESH:C538324), ENKTL (MESH:D054391), infection (MESH:D007239), pleural, peritoneal, pericardial, or cerebrospinal effusions (MESH:D010996), retroperitoneal (MESH:D012186), B-cell lymphoma (MESH:D016393), tenderness (MESH:D063806), adenocarcinoma (MESH:D000230), polyps (MESH:D011127), malignancy (MESH:D009369), inflammatory bowel disease (MESH:D015212), intestinal tuberculosis (MESH:D014376), peritoneal effusion (MESH:D010538), diarrhea (MESH:D003967), inflammatory (MESH:D007249), malignant effusion (MESH:D016066), lymphomatous disease (MESH:D013967), enteritis (MESH:D004751), vomiting (MESH:D014839), abdominal distension (MESH:D000007), tubal circulation disorders (MESH:D005184), abdominal pain (MESH:D015746), weight loss (MESH:D015431), lymphadenopathies (MESH:D008206), EBV infection (MESH:D020031), Small intestinal NK/T-cell lymphoma (MESH:D015451), peripheral T-cell lymphoma of the gastrointestinal tract (MESH:D016411), fever (MESH:D005334), T-L (MESH:D001260), lymphoid disorders (MESH:D008224), Extranodal lymphoma (MESH:D008223), constipation (MESH:D003248), death (MESH:D003643), ulcer (MESH:D014456)
- **Chemicals:** Cyclophosphamide (MESH:D003520), dexamethasone (MESH:D003907), Prednisone (MESH:D011241), Oncovin (MESH:D014750), Pap (MESH:D010724), CHOP (-), etoposide (MESH:D005047), ifosfamide (MESH:D007069), doxorubicin (MESH:D004317), rituximab (MESH:D000069283), HE (MESH:D006371), methotrexate (MESH:D008727)
- **Species:** Homo sapiens (human, species) [taxon 9606], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12321547/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12321547/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12321547/full.md

---
Source: https://tomesphere.com/paper/PMC12321547